Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2005

01-05-2005

The Maturation of Myeloma Cells Correlates with Sensitivity to Chemotherapeutic Agents

Authors: Yoshiaki Kuroda, Akira Sakai, Yoshiko Okikawa, Shoso Munemasa, Yuta Katayama, Hideo Hyodo, Jun Imagawa, Yasuo Takimoto, Hajime Okita, Megu Ohtaki, Akiro Kimura

Published in: International Journal of Hematology | Issue 4/2005

Login to get access
Metadata
Title
The Maturation of Myeloma Cells Correlates with Sensitivity to Chemotherapeutic Agents
Authors
Yoshiaki Kuroda
Akira Sakai
Yoshiko Okikawa
Shoso Munemasa
Yuta Katayama
Hideo Hyodo
Jun Imagawa
Yasuo Takimoto
Hajime Okita
Megu Ohtaki
Akiro Kimura
Publication date
01-05-2005
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2005
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04189

Other articles of this Issue 4/2005

International Journal of Hematology 4/2005 Go to the issue

OriginalPaper

Of Mice, Flies, and Man: The Emerging Role of Polycomb-Group Genes in Human Malignant Lymphomas

Case Report

A Case of Adolescent Primary Adrenal Natural Killer Cell Lymphoma

Case Report

Response to Imatinib Mesylate in a Patient with Idiopathic Hypereosinophilic Syndrome Associated with Cyclic Eosinophil Oscillations

OriginalPaper

Epigenetic Regulation of Hematopoietic Stem Cell Self-Renewal by Polycomb Group Genes

Case Report

Fatal Fulminant Hepatitis B after Withdrawal of Prophylactic Lamivudine in Hematopoietic Stem Cell Transplantation Patients

OriginalPaper

The Platelet Count/Mean Corpuscular Hemoglobin Ratio Distinguishes Combined Iron and Vitamin B12 Deficiency from Uncomplicated Iron Deficiency
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits